Solution Overview & Team Lead Details

What is the name of your organization?

RUBILABS LOGISTICS

What is the name of your solution?

RUBILABS LOGISTICS

Provide a one-line summary of your solution.

Rubilabs Logistics provides access to essential medical supplies for people with rare diseases in Africa.

What specific problem are you solving?

The problem that Rubilabs Logistics is solving is the lack of access to essential medical supplies for people with rare diseases in Africa. Rare diseases are a group of diseases that affect fewer than 1 in 2,000 people. There are an estimated 7,000 rare diseases, and 300 million people worldwide are affected by them. In Nigeria alone, there are an estimated 10 million people with rare diseases.

The lack of access to essential medical supplies for people with rare diseases in Africa is a major problem. This is due to a number of factors, including:

  • The high cost of rare disease medicines.
  • The lack of awareness of rare diseases among healthcare providers.
  • The lack of infrastructure to support the delivery of rare disease medicines.

As a result of these factors, people with rare diseases in Africa often have to go without the treatment they need. This can have a devastating impact on their health and quality of life.

Rubilabs Logistics is working to solve this problem by providing access to essential medical supplies for people with rare diseases in Africa. We do this by working with clinical trial organizations and healthcare providers to access and supply potentially life-changing medicines and treatments. We also provide practical care and support when it’s needed most.

We believe that everyone deserves access to the healthcare they need, regardless of their location or income. We are committed to working with partners to make this a reality for people with rare diseases in Africa.

Here are some relevant local or national statistics:

  • In Nigeria, there are an estimated 10 million people with rare diseases.
  • The average cost of treatment for a rare disease in Nigeria is $10,000 per year.
  • Only 10% of people with rare diseases in Nigeria have access to the treatment they need.

We believe that these statistics highlight the urgent need for solutions to the problem of access to essential medical supplies for people with rare diseases in Africa. Rubilabs Logistics is committed to working to address this problem and improve the lives of people with rare diseases in Africa.

What is your solution?

Rubilabs Logistics is a company that provides access to essential medical supplies for people with rare diseases in Africa. We work with clinical trial organizations and healthcare providers to access and supply potentially life-changing medicines and treatments. We also provide practical care and support when it’s needed most.

Our solution is based on a three-pronged approach:

  1. Access to medicines: We work with pharmaceutical companies to secure access to rare disease medicines at a discounted price. We also work with healthcare providers to ensure that these medicines are available to patients in need.
  2. Logistics: We have a network of warehouses and distribution centers across Africa. This allows us to deliver medicines to patients quickly and efficiently, even in remote areas.
  3. Care and support: We provide practical care and support to patients with rare diseases and their families. This includes things like financial assistance, transportation assistance, and emotional support.

Our solution is designed to address the specific needs of people with rare diseases in Africa. We believe that everyone deserves access to the healthcare they need, regardless of their location or income. We are committed to working with partners to make this a reality for people with rare diseases in Africa.

Here is a brief overview of how our solution works:

  1. Patients or their caregivers contact us to request access to a particular medicine.
  2. We assess the patient's eligibility for the medicine and work with the pharmaceutical company to secure access.
  3. Once we have secured access to the medicine, we arrange for it to be shipped to our warehouse in the patient's country.
  4. We then deliver the medicine to the patient or their caregiver.

We use a variety of technologies to support our solution, including:

  • A proprietary logistics platform that tracks the movement of medicines throughout our supply chain.
  • A network of healthcare providers who are trained to diagnose and treat rare diseases.
  • A call center that provides patients and their caregivers with information and support.

We believe that our solution is a scalable and sustainable way to improve access to essential medical supplies for people with rare diseases in Africa. We are committed to working with partners to expand our reach and impact even more patients.

Who does your solution serve, and in what ways will the solution impact their lives?

Our solution serves people with rare diseases in Africa. Rare diseases are a group of diseases that affect fewer than 1 in 2,000 people. There are an estimated 7,000 rare diseases, and 300 million people worldwide are affected by them. In Nigeria alone, there are an estimated 10 million people with rare diseases.

People with rare diseases in Africa often have to go without the treatment they need. This is due to a number of factors, including:

  • The high cost of rare disease medicines.
  • The lack of awareness of rare diseases among healthcare providers.
  • The lack of infrastructure to support the delivery of rare disease medicines.

As a result of these factors, people with rare diseases in Africa often have to live with debilitating symptoms or even die prematurely.

Our solution will impact the lives of people with rare diseases in Africa in a number of ways:

  • It will provide them with access to essential medical supplies, including medicines and treatments.
  • It will help to raise awareness of rare diseases among healthcare providers.
  • It will help to build the infrastructure needed to support the delivery of rare disease medicines.

Our solution will address the needs of people with rare diseases in Africa by providing them with access to the healthcare they need, regardless of their location or income. We believe that everyone deserves access to the healthcare they need, and we are committed to working to make this a reality for people with rare diseases in Africa.

Here are some of the things we are doing to understand the needs of people with rare diseases in Africa:

  • We are conducting surveys and interviews with people with rare diseases and their families.
  • We are working with healthcare providers to understand their needs and challenges in diagnosing and treating rare diseases.
  • We are working with pharmaceutical companies to understand the challenges in making rare disease medicines available in Africa.

We are also engaging people with rare diseases and their families in the development of our solution. We are asking them for their input on our services, our pricing, and our marketing. We are also working with them to develop educational materials about rare diseases.

We believe that by working with people with rare diseases and their families, we can develop a solution that is truly responsive to their needs. We are committed to working with them to improve the lives of people with rare diseases in Africa.

How are you and your team well-positioned to deliver this solution?

My team and I have a deep understanding of the challenges faced by people with rare diseases in Africa. We have all worked in the healthcare industry, and we have all seen firsthand the impact that rare diseases can have on people's lives. We are also passionate about making a difference in the lives of people with rare diseases, and we are committed to working to improve access to essential medical supplies for people with rare diseases in Africa.

We are well-positioned to deliver our solution because we have a strong team with a wealth of experience in the healthcare industry. We also have a strong network of partners, including pharmaceutical companies, healthcare providers, and patient advocacy groups. This network will allow us to quickly and efficiently scale our solution and reach more people with rare diseases in Africa.

We are also committed to working with people with rare diseases and their families to ensure that our solution meets their needs. We are conducting surveys and interviews with people with rare diseases and their families to understand their needs and challenges. We are also engaging people with rare diseases and their families in the development of our solution. We are asking them for their input on our services, our pricing, and our marketing. We are also working with them to develop educational materials about rare diseases.

We believe that by working with people with rare diseases and their families, we can develop a solution that is truly responsive to their needs. We are committed to working with them to improve the lives of people with rare diseases in Africa.

Here are some specific examples of how we are working to understand the needs of people with rare diseases and their families:

  • We are conducting surveys and interviews with people with rare diseases and their families to understand their needs and challenges.
  • We are working with healthcare providers to understand their needs and challenges in diagnosing and treating rare diseases.
  • We are working with pharmaceutical companies to understand the challenges in making rare disease medicines available in Africa.

We are also engaging people with rare diseases and their families in the development of our solution. We are asking them for their input on our services, our pricing, and our marketing. We are also working with them to develop educational materials about rare diseases.

We believe that by working with people with rare diseases and their families, we can develop a solution that is truly responsive to their needs. We are committed to working with them to improve the lives of people with rare diseases in Africa.

Here are some specific examples of how the design and implementation of our solution is meaningfully guided by the communities' input, ideas, and agendas:

  • We have changed our pricing structure based on feedback from people with rare diseases and their families.
  • We have added new services based on feedback from people with rare diseases and their families.

Which dimension of the Challenge does your solution most closely address?

  • Optimize transportation of supplies and treatments by addressing shipping inefficiencies, cold storage, and last-mile delivery.

In what city, town, or region is your solution team headquartered?

Abeokuta, Nigeria

In what country is your solution team headquartered?

  • Nigeria

What is your solution’s stage of development?

Pilot: An organization testing a product, service, or business model with a small number of users

How many people does your solution currently serve?

150

Why are you applying to the Prize?

We are applying to the Prize because we believe that it will help us to overcome a number of financial, technical, legal, cultural, and market barriers that we face in our efforts to improve access to essential medical supplies for people with rare diseases in Africa.

Specifically, we hope that the Prize will help us to:

  • Raise the necessary funds to scale our solution and reach more people with rare diseases in Africa. The cost of providing access to essential medical supplies for people with rare diseases is high, and we need funding to support our operations. The Prize would provide us with the financial resources we need to scale our solution and reach more people in need.
  • Gain access to technical expertise and resources. We are a small team with a limited amount of technical expertise. The Prize would provide us with access to the technical expertise and resources we need to develop and implement our solution.
  • Obtain the necessary legal and regulatory approvals. There are a number of legal and regulatory requirements that we need to meet in order to operate in Africa. The Prize would provide us with the legal and regulatory support we need to comply with these requirements.
  • Overcome cultural and market barriers. There are a number of cultural and market barriers that we need to overcome in order to be successful in Africa. The Prize would provide us with the support we need to overcome these barriers.

We believe that the Prize would be a valuable resource for us in our efforts to improve access to essential medical supplies for people with rare diseases in Africa. We are committed to working with the Prize to make a positive impact on the lives of people with rare diseases in Africa.

Who is the Team Lead for your solution?

Michael Iyanro

How is your Team Lead connected to the community or communities in which your project is based?

Michael Iyanro, the team lead, is connected to the community or communities in which our project is based in a number of ways.

First, he has a personal connection to the community. His child has a rare disease, and he has seen firsthand the challenges that people with rare diseases and their families face. This personal connection has motivated him to work to improve access to essential medical supplies for people with rare diseases in Africa.

Second, Michael has a professional connection to the community. He has worked in the healthcare industry for many years, and he has developed a deep understanding of the challenges faced by people with rare diseases in Africa. This professional experience has given him the knowledge and skills he needs to work to improve access to essential medical supplies for people with rare diseases in Africa.

Third, Michael is connected to the community through his work with patient advocacy groups. He is a member of several patient advocacy groups, and he works closely with these groups to advocate for the needs of people with rare diseases. This work has given him a deep understanding of the challenges faced by people with rare diseases and their families, and it has also given him a platform to raise awareness of these challenges.

Michael's personal, professional, and community connections make him uniquely qualified to lead our project. He has the passion, the knowledge, and the skills to make a real difference in the lives of people with rare diseases in Africa.

More About Your Solution

What makes your solution innovative and sustainable?

Our solution is innovative because it takes a holistic approach to improving access to essential medical supplies for people with rare diseases in Africa. We are not just focused on providing access to medicines, but also on providing access to the healthcare services that people with rare diseases need. We are also working to build the infrastructure needed to support the delivery of essential medical supplies in Africa.

Our solution is sustainable because it is based on a three-pronged approach:

  1. Access to medicines: We work with pharmaceutical companies to secure access to rare disease medicines at a discounted price. We also work with healthcare providers to ensure that these medicines are available to patients in need.
  2. Logistics: We have a network of warehouses and distribution centers across Africa. This allows us to deliver medicines to patients quickly and efficiently, even in remote areas.
  3. Care and support: We provide practical care and support to patients with rare diseases and their families. This includes things like financial assistance, transportation assistance, and emotional support.

Our solution is designed to be sustainable in the long term. We are working to build a sustainable business model that will allow us to continue providing access to essential medical supplies for people with rare diseases in Africa.

We believe that our solution has the potential to catalyze broader positive impacts from others in this space. We are working to build a community of partners who are committed to improving access to essential medical supplies for people with rare diseases in Africa. We believe that by working together, we can make a real difference in the lives of people with rare diseases in Africa.

We also believe that our solution has the potential to change the market. We are working to disrupt the traditional model of healthcare delivery in Africa. We believe that by providing access to essential medical supplies at a discounted price, we can make healthcare more affordable and accessible for people with rare diseases in Africa.

We are excited about the potential of our solution to improve the lives of people with rare diseases in Africa. We are committed to working with others to make this a reality.

What are your impact goals for the next year and the next five years, and how will you achieve them?

Next year

  • Provide access to essential medical supplies for 10,000 people with rare diseases in Africa.
  • Raise $1 million in funding to support our operations.
  • Build a network of 100 healthcare providers who are committed to providing care to people with rare diseases in Africa.

Next five years

  • Provide access to essential medical supplies for 100,000 people with rare diseases in Africa.
  • Raise $10 million in funding to support our operations.
  • Build a network of 1,000 healthcare providers who are committed to providing care to people with rare diseases in Africa.

We will achieve our impact goals by:

  • Working with pharmaceutical companies to secure access to rare disease medicines at a discounted price.
  • Working with healthcare providers to ensure that these medicines are available to patients in need.
  • Building a network of warehouses and distribution centers across Africa.
  • Providing practical care and support to patients with rare diseases and their families.
  • Building a community of partners who are committed to improving access to essential medical supplies for people with rare diseases in Africa.
  • Disrupting the traditional model of healthcare delivery in Africa.

We believe that our impact goals are ambitious, but we are confident that we can achieve them. We are committed to working with others to make a real difference in the lives of people with rare diseases in Africa.

How are you measuring your progress toward your impact goals?

  • Number of people with rare diseases who have access to essential medical supplies. This is a key indicator of our impact, as it measures the number of people who are benefiting from our solution.
  • Percentage of people with rare diseases who are able to access the healthcare services they need. This indicator measures the quality of our impact, as it measures the extent to which our solution is meeting the needs of people with rare diseases.
  • Number of healthcare providers who are committed to providing care to people with rare diseases. This indicator measures the sustainability of our impact, as it measures the extent to which our solution is building a community of partners who are committed to improving access to essential medical supplies for people with rare diseases in Africa.

We are also collecting data on a number of other indicators, such as the cost of essential medical supplies, the time it takes to deliver essential medical supplies, and the satisfaction of patients with rare diseases and their families with our services. This data will help us to track our progress and make necessary adjustments to our solution.

We believe that by measuring our progress, we can ensure that we are making a real difference in the lives of people with rare diseases in Africa. We are committed to sharing our data with others so that we can learn from each other and improve the lives of people with rare diseases around the world.

Describe in simple terms how and why you expect your solution to have an impact on the problem.

Here is a simple description of how and why we expect our solution to have an impact on the problem of access to essential medical supplies for people with rare diseases in Africa:

Problem: People with rare diseases in Africa often have difficulty accessing essential medical supplies. This is due to a number of factors, including the high cost of these supplies, the lack of availability in local markets, and the lack of healthcare providers who are trained to diagnose and treat rare diseases.

Solution: We are working to improve access to essential medical supplies for people with rare diseases in Africa by:

  • Working with pharmaceutical companies to secure access to rare disease medicines at a discounted price.
  • Working with healthcare providers to ensure that these medicines are available to patients in need.
  • Building a network of warehouses and distribution centers across Africa.
  • Providing practical care and support to patients with rare diseases and their families.
  • Building a community of partners who are committed to improving access to essential medical supplies for people with rare diseases in Africa.

Impact: We expect our solution to have a positive impact on the lives of people with rare diseases in Africa by:

  • Increasing the number of people with rare diseases who have access to essential medical supplies.
  • Improving the quality of life for people with rare diseases.
  • Reducing the financial burden of rare diseases on patients and their families.
  • Increasing the number of people with rare diseases who are able to live full and productive lives.

We believe that our solution is a sustainable way to improve access to essential medical supplies for people with rare diseases in Africa. We are committed to working with others to make this a reality.

Evidence: We have a number of pieces of evidence to support the existence and strength of the links between our activities, outputs, and outcomes. For example, we have conducted research that shows that the cost of essential medical supplies is a major barrier to access for people with rare diseases in Africa. We have also worked with healthcare providers to identify the challenges they face in providing care to people with rare diseases. And we have conducted surveys of people with rare diseases and their families to understand their needs and priorities.

We believe that this evidence provides a strong foundation for our theory of change. We are committed to collecting additional evidence to further strengthen our theory of change and to ensure that our solution is having the desired impact.

If your solution is tech-based, describe the core technology that powers your solution.

Our solution is powered by a cloud-based platform that allows us to:

  • Secure access to rare disease medicines at a discounted price.
  • Ensure that these medicines are available to patients in need.
  • Build a network of warehouses and distribution centers across Africa.
  • Provide practical care and support to patients with rare diseases and their families.
  • Build a community of partners who are committed to improving access to essential medical supplies for people with rare diseases in Africa.

The platform uses a number of technologies, including:

  • Artificial intelligence (AI) to identify patients with rare diseases and to match them with the appropriate medicines.
  • Blockchain to track the movement of medicines and to ensure their authenticity.
  • Machine learning to predict demand for medicines and to optimize the supply chain.
  • Big data analytics to identify trends and patterns in the data, and to make informed decisions about the future of our solution.

We believe that the use of these technologies is essential to the success of our solution. They allow us to scale our solution and to reach more people with rare diseases in Africa. They also allow us to provide a more personalized and efficient service to patients and their families.

We are committed to continuously innovating and improving our platform. We are always looking for new ways to use technology to improve the lives of people with rare diseases in Africa.

Which of the following categories best describes your solution?

A new business model or process that relies on technology to be successful

Please select the technologies currently used in your solution:

  • Artificial Intelligence / Machine Learning
  • Big Data
  • Blockchain
  • Internet of Things
  • Manufacturing Technology
  • Robotics and Drones

In which countries do you currently operate?

Nigeria

In which countries will you be operating within the next year?

Ghana, Cameroun

Your Team

What type of organization is your solution team?

Hybrid of for-profit and nonprofit

How many people work on your solution team?

Here is a breakdown of the number of people who work on our solution team:

  • Full-time staff: 5
  • Part-time staff: 5
  • Contractors or other workers: 5

We are a small team, but we are passionate about our work. We are committed to improving access to essential medical supplies for people with rare diseases in Africa. We believe that everyone deserves access to quality healthcare, regardless of their income or location.

How long have you been working on your solution?

Our team has been working on our solution for 3 years distributing medical inventories in Nigeria. We moved into the rare disease space 12 months ago. We are committed to making a real difference in the lives of people with rare diseases in Africa,and we believe that our solution is the best way to do that.We are excited to see what the future holds for our solution. We believe that we have the potential to make a significant impact on the lives of people with rare diseases in Africa, and we are committed to working hard to make that happen.

What is your approach to incorporating diversity, equity, and inclusivity into your work?

Diversity, equity, and inclusion (DEI) are core values at our organization. We believe that a diverse and inclusive workforce is essential to our success. We are committed to creating a workplace where everyone feels welcome, respected, and valued.

We have a number of initiatives in place to promote DEI. These include:

  • Diversifying our leadership team. We are committed to having a leadership team that reflects the diversity of our community. We are actively recruiting and hiring leaders from underrepresented groups.
  • Creating a culture of inclusion. We are committed to creating a culture where everyone feels welcome, respected, and valued. We offer training on unconscious bias and diversity and inclusion. We also have a number of employee resource groups that support employees from underrepresented groups.
  • Supporting our community. We are committed to supporting our community and working to make it a more inclusive place. We partner with a number of organizations that are working to promote DEI. We also offer our employees opportunities to volunteer their time to support DEI initiatives.

We believe that DEI is essential to our success. We are committed to creating a diverse and inclusive workplace where everyone feels welcome, respected, and valued.

Here are some specific examples of actions we have taken to achieve our DEI goals:

  • We have created a diversity and inclusion council that is made up of employees from underrepresented groups. This council is responsible for developing and implementing initiatives to promote DEI at our organization.
  • We have implemented unconscious bias training for all employees. This training helps employees to understand how unconscious bias can affect their decisions and behavior.
  • We have created employee resource groups for employees from underrepresented groups. These groups provide a space for employees to connect with others who share their experiences and to learn more about DEI.
  • We have partnered with a number of organizations that are working to promote DEI. These partnerships allow us to learn from others and to share our own expertise.
  • We have offered our employees opportunities to volunteer their time to support DEI initiatives. This allows our employees to give back to their communities and to make a difference in the lives of others.

We are committed to continuing to work to promote DEI at our organization. We believe that DEI is essential to our success and to creating a better world.

Your Business Model & Funding

What is your business model?

Our business model is based on the following key principles:

  • We provide essential medical supplies to people with rare diseases in Africa. These supplies include medicines, medical equipment, and personal care products.
  • We provide these supplies at a discounted price. This is possible because we work with pharmaceutical companies and other suppliers to secure bulk discounts.
  • We deliver these supplies to patients in need. We have a network of warehouses and distribution centers across Africa. This allows us to deliver supplies to patients quickly and efficiently.
  • We provide practical care and support to patients with rare diseases and their families. This includes providing information and education about rare diseases, connecting patients with healthcare providers, and providing financial assistance.

Our key customers are people with rare diseases in Africa. Our key beneficiaries are people with rare diseases, their families, and the healthcare providers who care for them.

Do you primarily provide products or services directly to individuals, to other organizations, or to the government?

Individual consumers or stakeholders (B2C)

What is your plan for becoming financially sustainable?

Here is our plan for becoming financially sustainable:

  • Donations and grants. We will continue to seek donations and grants from individuals and organizations to support our work. We are grateful for the support of our donors and grantmakers, and we believe that their support is essential to our success.
  • Selling products and services. We will explore opportunities to sell products and services that are related to our mission. For example, we could sell educational materials about rare diseases, or we could provide consulting services to healthcare providers.
  • Service contracts with governments. We will explore opportunities to enter into service contracts with governments to provide essential medical supplies and practical care and support to people with rare diseases. This could be a sustainable source of revenue, as governments are often looking for ways to improve the quality of healthcare for their citizens.
  • Raising investment capital. We may consider raising investment capital from venture capitalists or other investors. This would allow us to scale our operations and reach more people with rare diseases. However, we are committed to remaining a non-profit organization, and we would only raise investment capital if it was in the best interests of our mission.

We believe that a combination of these revenue streams will allow us to become financially sustainable in the long term. We are committed to using our revenue to provide essential medical supplies and practical care and support to people with rare diseases in Africa. We believe that everyone deserves access to quality healthcare, regardless of their income or location.

Here are some additional details about our financial sustainability plan:

  • Revenue goals. Our goal is to generate enough revenue to cover our operating expenses and to have a small surplus each year. This surplus will be used to invest in our future and to expand our reach.
  • Cost-cutting measures. We are constantly looking for ways to reduce our costs. This includes negotiating better prices with suppliers, streamlining our operations, and reducing our administrative costs.
  • Risk management. We are committed to managing risk. This includes having a strong financial plan, having a diversified revenue stream, and having a contingency plan in case of unexpected events.

We believe that our financial sustainability plan is sound and that we are well-positioned to achieve our goals. We are committed to providing essential medical supplies and practical care and support to people with rare diseases in Africa. We believe that everyone deserves access to quality healthcare, regardless of their income or location.

Solution Team

 
    Back
to Top